ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma Sustained Release Excipient Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-15L12733
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma Sustained Release Excipient Market Research Report 2022
BUY CHAPTERS

Global Pharma Sustained Release Excipient Market Research Report 2025

Code: QYRE-Auto-15L12733
Report
February 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer Inc
Sun Pharmaceutical Industries
Novartis
Astrazeneca plc
Janssen Pharmaceuticals
Mayne Pharma Group
BASF AG
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
GlaxoSmithKline PLC
Allergan plc
Teva Pharmaceutical Industries

Pharma Sustained Release Excipient Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharma Sustained Release Excipient Market

Pharma Sustained Release Excipient Market

The global market for Pharma Sustained Release Excipient was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharma Sustained Release Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sustained Release Excipient.
The Pharma Sustained Release Excipient market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Sustained Release Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Sustained Release Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharma Sustained Release Excipient Market Report

Report Metric Details
Report Name Pharma Sustained Release Excipient Market
CAGR 5%
Segment by Type
  • Gelatin
  • Polymers
  • Minerals
  • Sugars
  • Chitosan
Segment by Application
  • Pharmaceutical
  • Health Care
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline, Allergan, Janssen Pharmaceuticals, Mayne Pharma Group, BASF, International Flavors & Fragrances, Ashland Global, Evonik Industries, Croda International, Gattefosse, Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharma Sustained Release Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharma Sustained Release Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pharma Sustained Release Excipient Market report?

Ans: The main players in the Pharma Sustained Release Excipient Market are Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline, Allergan, Janssen Pharmaceuticals, Mayne Pharma Group, BASF, International Flavors & Fragrances, Ashland Global, Evonik Industries, Croda International, Gattefosse, Merck KGaA

What are the Application segmentation covered in the Pharma Sustained Release Excipient Market report?

Ans: The Applications covered in the Pharma Sustained Release Excipient Market report are Pharmaceutical, Health Care, Others

What are the Type segmentation covered in the Pharma Sustained Release Excipient Market report?

Ans: The Types covered in the Pharma Sustained Release Excipient Market report are Gelatin, Polymers, Minerals, Sugars, Chitosan

1 Pharma Sustained Release Excipient Market Overview
1.1 Product Definition
1.2 Pharma Sustained Release Excipient by Type
1.2.1 Global Pharma Sustained Release Excipient Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gelatin
1.2.3 Polymers
1.2.4 Minerals
1.2.5 Sugars
1.2.6 Chitosan
1.3 Pharma Sustained Release Excipient by Application
1.3.1 Global Pharma Sustained Release Excipient Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical
1.3.3 Health Care
1.3.4 Others
1.4 Global Pharma Sustained Release Excipient Market Size Estimates and Forecasts
1.4.1 Global Pharma Sustained Release Excipient Revenue 2020-2031
1.4.2 Global Pharma Sustained Release Excipient Sales 2020-2031
1.4.3 Global Pharma Sustained Release Excipient Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharma Sustained Release Excipient Market Competition by Manufacturers
2.1 Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharma Sustained Release Excipient Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharma Sustained Release Excipient Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharma Sustained Release Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharma Sustained Release Excipient, Product Type & Application
2.7 Global Key Manufacturers of Pharma Sustained Release Excipient, Date of Enter into This Industry
2.8 Global Pharma Sustained Release Excipient Market Competitive Situation and Trends
2.8.1 Global Pharma Sustained Release Excipient Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharma Sustained Release Excipient Players Market Share by Revenue
2.8.3 Global Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharma Sustained Release Excipient Market Scenario by Region
3.1 Global Pharma Sustained Release Excipient Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharma Sustained Release Excipient Sales by Region: 2020-2031
3.2.1 Global Pharma Sustained Release Excipient Sales by Region: 2020-2025
3.2.2 Global Pharma Sustained Release Excipient Sales by Region: 2026-2031
3.3 Global Pharma Sustained Release Excipient Revenue by Region: 2020-2031
3.3.1 Global Pharma Sustained Release Excipient Revenue by Region: 2020-2025
3.3.2 Global Pharma Sustained Release Excipient Revenue by Region: 2026-2031
3.4 North America Pharma Sustained Release Excipient Market Facts & Figures by Country
3.4.1 North America Pharma Sustained Release Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharma Sustained Release Excipient Sales by Country (2020-2031)
3.4.3 North America Pharma Sustained Release Excipient Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharma Sustained Release Excipient Market Facts & Figures by Country
3.5.1 Europe Pharma Sustained Release Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharma Sustained Release Excipient Sales by Country (2020-2031)
3.5.3 Europe Pharma Sustained Release Excipient Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma Sustained Release Excipient Market Facts & Figures by Region
3.6.1 Asia Pacific Pharma Sustained Release Excipient Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharma Sustained Release Excipient Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharma Sustained Release Excipient Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharma Sustained Release Excipient Market Facts & Figures by Country
3.7.1 Latin America Pharma Sustained Release Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharma Sustained Release Excipient Sales by Country (2020-2031)
3.7.3 Latin America Pharma Sustained Release Excipient Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma Sustained Release Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma Sustained Release Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharma Sustained Release Excipient Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma Sustained Release Excipient Sales by Type (2020-2031)
4.1.1 Global Pharma Sustained Release Excipient Sales by Type (2020-2025)
4.1.2 Global Pharma Sustained Release Excipient Sales by Type (2026-2031)
4.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Type (2020-2031)
4.2 Global Pharma Sustained Release Excipient Revenue by Type (2020-2031)
4.2.1 Global Pharma Sustained Release Excipient Revenue by Type (2020-2025)
4.2.2 Global Pharma Sustained Release Excipient Revenue by Type (2026-2031)
4.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Type (2020-2031)
4.3 Global Pharma Sustained Release Excipient Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharma Sustained Release Excipient Sales by Application (2020-2031)
5.1.1 Global Pharma Sustained Release Excipient Sales by Application (2020-2025)
5.1.2 Global Pharma Sustained Release Excipient Sales by Application (2026-2031)
5.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Application (2020-2031)
5.2 Global Pharma Sustained Release Excipient Revenue by Application (2020-2031)
5.2.1 Global Pharma Sustained Release Excipient Revenue by Application (2020-2025)
5.2.2 Global Pharma Sustained Release Excipient Revenue by Application (2026-2031)
5.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Application (2020-2031)
5.3 Global Pharma Sustained Release Excipient Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Company Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Mylan N.V.
6.2.1 Mylan N.V. Company Information
6.2.2 Mylan N.V. Description and Business Overview
6.2.3 Mylan N.V. Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan N.V. Pharma Sustained Release Excipient Product Portfolio
6.2.5 Mylan N.V. Recent Developments/Updates
6.3 Valeant Pharmaceuticals International
6.3.1 Valeant Pharmaceuticals International Company Information
6.3.2 Valeant Pharmaceuticals International Description and Business Overview
6.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Portfolio
6.3.5 Valeant Pharmaceuticals International Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Pharma Sustained Release Excipient Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Company Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Company Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis AG Pharma Sustained Release Excipient Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Pharma Sustained Release Excipient Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline Pharma Sustained Release Excipient Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Company Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Allergan Pharma Sustained Release Excipient Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Janssen Pharmaceuticals
6.10.1 Janssen Pharmaceuticals Company Information
6.10.2 Janssen Pharmaceuticals Description and Business Overview
6.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Portfolio
6.10.5 Janssen Pharmaceuticals Recent Developments/Updates
6.11 Mayne Pharma Group
6.11.1 Mayne Pharma Group Company Information
6.11.2 Mayne Pharma Group Description and Business Overview
6.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mayne Pharma Group Pharma Sustained Release Excipient Product Portfolio
6.11.5 Mayne Pharma Group Recent Developments/Updates
6.12 BASF
6.12.1 BASF Company Information
6.12.2 BASF Description and Business Overview
6.12.3 BASF Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BASF Pharma Sustained Release Excipient Product Portfolio
6.12.5 BASF Recent Developments/Updates
6.13 International Flavors & Fragrances
6.13.1 International Flavors & Fragrances Company Information
6.13.2 International Flavors & Fragrances Description and Business Overview
6.13.3 International Flavors & Fragrances Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.13.4 International Flavors & Fragrances Pharma Sustained Release Excipient Product Portfolio
6.13.5 International Flavors & Fragrances Recent Developments/Updates
6.14 Ashland Global
6.14.1 Ashland Global Company Information
6.14.2 Ashland Global Description and Business Overview
6.14.3 Ashland Global Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ashland Global Pharma Sustained Release Excipient Product Portfolio
6.14.5 Ashland Global Recent Developments/Updates
6.15 Evonik Industries
6.15.1 Evonik Industries Company Information
6.15.2 Evonik Industries Description and Business Overview
6.15.3 Evonik Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Evonik Industries Pharma Sustained Release Excipient Product Portfolio
6.15.5 Evonik Industries Recent Developments/Updates
6.16 Croda International
6.16.1 Croda International Company Information
6.16.2 Croda International Description and Business Overview
6.16.3 Croda International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Croda International Pharma Sustained Release Excipient Product Portfolio
6.16.5 Croda International Recent Developments/Updates
6.17 Gattefosse
6.17.1 Gattefosse Company Information
6.17.2 Gattefosse Description and Business Overview
6.17.3 Gattefosse Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Gattefosse Pharma Sustained Release Excipient Product Portfolio
6.17.5 Gattefosse Recent Developments/Updates
6.18 Merck KGaA
6.18.1 Merck KGaA Company Information
6.18.2 Merck KGaA Description and Business Overview
6.18.3 Merck KGaA Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Merck KGaA Pharma Sustained Release Excipient Product Portfolio
6.18.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma Sustained Release Excipient Industry Chain Analysis
7.2 Pharma Sustained Release Excipient Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma Sustained Release Excipient Production Mode & Process Analysis
7.4 Pharma Sustained Release Excipient Sales and Marketing
7.4.1 Pharma Sustained Release Excipient Sales Channels
7.4.2 Pharma Sustained Release Excipient Distributors
7.5 Pharma Sustained Release Excipient Customer Analysis
8 Pharma Sustained Release Excipient Market Dynamics
8.1 Pharma Sustained Release Excipient Industry Trends
8.2 Pharma Sustained Release Excipient Market Drivers
8.3 Pharma Sustained Release Excipient Market Challenges
8.4 Pharma Sustained Release Excipient Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer Inc
Sun Pharmaceutical Industries
Novartis
Astrazeneca plc
Janssen Pharmaceuticals
Mayne Pharma Group
BASF AG
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
GlaxoSmithKline PLC
Allergan plc
Teva Pharmaceutical Industries
List of Tables
 Table 1. Global Pharma Sustained Release Excipient Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pharma Sustained Release Excipient Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pharma Sustained Release Excipient Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pharma Sustained Release Excipient Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pharma Sustained Release Excipient Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pharma Sustained Release Excipient, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharma Sustained Release Excipient, Product Type & Application
 Table 12. Global Key Manufacturers of Pharma Sustained Release Excipient, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharma Sustained Release Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharma Sustained Release Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pharma Sustained Release Excipient Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Pharma Sustained Release Excipient Sales Market Share by Region (2020-2025)
 Table 19. Global Pharma Sustained Release Excipient Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Pharma Sustained Release Excipient Sales Market Share by Region (2026-2031)
 Table 21. Global Pharma Sustained Release Excipient Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2020-2025)
 Table 23. Global Pharma Sustained Release Excipient Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2026-2031)
 Table 25. North America Pharma Sustained Release Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pharma Sustained Release Excipient Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Pharma Sustained Release Excipient Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Pharma Sustained Release Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pharma Sustained Release Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pharma Sustained Release Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pharma Sustained Release Excipient Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Pharma Sustained Release Excipient Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Pharma Sustained Release Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pharma Sustained Release Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pharma Sustained Release Excipient Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Pharma Sustained Release Excipient Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pharma Sustained Release Excipient Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharma Sustained Release Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pharma Sustained Release Excipient Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Pharma Sustained Release Excipient Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Pharma Sustained Release Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharma Sustained Release Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pharma Sustained Release Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Pharma Sustained Release Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pharma Sustained Release Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pharma Sustained Release Excipient Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Pharma Sustained Release Excipient Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Pharma Sustained Release Excipient Sales Market Share by Type (2020-2025)
 Table 53. Global Pharma Sustained Release Excipient Sales Market Share by Type (2026-2031)
 Table 54. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2020-2025)
 Table 57. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2026-2031)
 Table 58. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Pharma Sustained Release Excipient Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Pharma Sustained Release Excipient Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Pharma Sustained Release Excipient Sales Market Share by Application (2020-2025)
 Table 63. Global Pharma Sustained Release Excipient Sales Market Share by Application (2026-2031)
 Table 64. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2020-2025)
 Table 67. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2026-2031)
 Table 68. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2026-2031)
 Table 70. Teva Pharmaceutical Industries Company Information
 Table 71. Teva Pharmaceutical Industries Description and Business Overview
 Table 72. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product
 Table 74. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 75. Mylan N.V. Company Information
 Table 76. Mylan N.V. Description and Business Overview
 Table 77. Mylan N.V. Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Mylan N.V. Pharma Sustained Release Excipient Product
 Table 79. Mylan N.V. Recent Developments/Updates
 Table 80. Valeant Pharmaceuticals International Company Information
 Table 81. Valeant Pharmaceuticals International Description and Business Overview
 Table 82. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product
 Table 84. Valeant Pharmaceuticals International Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Pfizer Pharma Sustained Release Excipient Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Sun Pharmaceutical Industries Company Information
 Table 91. Sun Pharmaceutical Industries Description and Business Overview
 Table 92. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product
 Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 95. Novartis AG Company Information
 Table 96. Novartis AG Description and Business Overview
 Table 97. Novartis AG Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Novartis AG Pharma Sustained Release Excipient Product
 Table 99. Novartis AG Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Pharma Sustained Release Excipient Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. GlaxoSmithKline Company Information
 Table 106. GlaxoSmithKline Description and Business Overview
 Table 107. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline Pharma Sustained Release Excipient Product
 Table 109. GlaxoSmithKline Recent Developments/Updates
 Table 110. Allergan Company Information
 Table 111. Allergan Description and Business Overview
 Table 112. Allergan Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Allergan Pharma Sustained Release Excipient Product
 Table 114. Allergan Recent Developments/Updates
 Table 115. Janssen Pharmaceuticals Company Information
 Table 116. Janssen Pharmaceuticals Description and Business Overview
 Table 117. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product
 Table 119. Janssen Pharmaceuticals Recent Developments/Updates
 Table 120. Mayne Pharma Group Company Information
 Table 121. Mayne Pharma Group Description and Business Overview
 Table 122. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Mayne Pharma Group Pharma Sustained Release Excipient Product
 Table 124. Mayne Pharma Group Recent Developments/Updates
 Table 125. BASF Company Information
 Table 126. BASF Description and Business Overview
 Table 127. BASF Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. BASF Pharma Sustained Release Excipient Product
 Table 129. BASF Recent Developments/Updates
 Table 130. International Flavors & Fragrances Company Information
 Table 131. International Flavors & Fragrances Description and Business Overview
 Table 132. International Flavors & Fragrances Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. International Flavors & Fragrances Pharma Sustained Release Excipient Product
 Table 134. International Flavors & Fragrances Recent Developments/Updates
 Table 135. Ashland Global Company Information
 Table 136. Ashland Global Description and Business Overview
 Table 137. Ashland Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Ashland Global Pharma Sustained Release Excipient Product
 Table 139. Ashland Global Recent Developments/Updates
 Table 140. Evonik Industries Company Information
 Table 141. Evonik Industries Description and Business Overview
 Table 142. Evonik Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. Evonik Industries Pharma Sustained Release Excipient Product
 Table 144. Evonik Industries Recent Developments/Updates
 Table 145. Croda International Company Information
 Table 146. Croda International Description and Business Overview
 Table 147. Croda International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. Croda International Pharma Sustained Release Excipient Product
 Table 149. Croda International Recent Developments/Updates
 Table 150. Gattefosse Company Information
 Table 151. Gattefosse Description and Business Overview
 Table 152. Gattefosse Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 153. Gattefosse Pharma Sustained Release Excipient Product
 Table 154. Gattefosse Recent Developments/Updates
 Table 155. Merck KGaA Company Information
 Table 156. Merck KGaA Description and Business Overview
 Table 157. Merck KGaA Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 158. Merck KGaA Pharma Sustained Release Excipient Product
 Table 159. Merck KGaA Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Pharma Sustained Release Excipient Distributors List
 Table 163. Pharma Sustained Release Excipient Customers List
 Table 164. Pharma Sustained Release Excipient Market Trends
 Table 165. Pharma Sustained Release Excipient Market Drivers
 Table 166. Pharma Sustained Release Excipient Market Challenges
 Table 167. Pharma Sustained Release Excipient Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharma Sustained Release Excipient
 Figure 2. Global Pharma Sustained Release Excipient Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharma Sustained Release Excipient Market Share by Type: 2024 & 2031
 Figure 4. Gelatin Product Picture
 Figure 5. Polymers Product Picture
 Figure 6. Minerals Product Picture
 Figure 7. Sugars Product Picture
 Figure 8. Chitosan Product Picture
 Figure 9. Global Pharma Sustained Release Excipient Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Pharma Sustained Release Excipient Market Share by Application: 2024 & 2031
 Figure 11. Pharmaceutical
 Figure 12. Health Care
 Figure 13. Others
 Figure 14. Global Pharma Sustained Release Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharma Sustained Release Excipient Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Pharma Sustained Release Excipient Sales (2020-2031) & (Kiloton)
 Figure 17. Global Pharma Sustained Release Excipient Average Price (US$/Ton) & (2020-2031)
 Figure 18. Pharma Sustained Release Excipient Report Years Considered
 Figure 19. Pharma Sustained Release Excipient Sales Share by Manufacturers in 2024
 Figure 20. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Pharma Sustained Release Excipient Players: Market Share by Revenue in Pharma Sustained Release Excipient in 2024
 Figure 22. Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Pharma Sustained Release Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Pharma Sustained Release Excipient Sales Market Share by Country (2020-2031)
 Figure 25. North America Pharma Sustained Release Excipient Revenue Market Share by Country (2020-2031)
 Figure 26. United States Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Pharma Sustained Release Excipient Sales Market Share by Country (2020-2031)
 Figure 29. Europe Pharma Sustained Release Excipient Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Pharma Sustained Release Excipient Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Pharma Sustained Release Excipient Revenue Market Share by Region (2020-2031)
 Figure 37. China Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Pharma Sustained Release Excipient Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Pharma Sustained Release Excipient Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Pharma Sustained Release Excipient Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Pharma Sustained Release Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Pharma Sustained Release Excipient by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Pharma Sustained Release Excipient by Type (2020-2031)
 Figure 56. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Pharma Sustained Release Excipient by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Pharma Sustained Release Excipient by Application (2020-2031)
 Figure 59. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2020-2031)
 Figure 60. Pharma Sustained Release Excipient Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Pharma Excipients Market Research Report 2024
Global Drug Excipients Market Research Report 2024
Global Organic Pharmaceutical Excipients Market Research Report 2024
Pharma Sustained Release Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical Excipients Market Insights Forecast to 2030
Global Active Pharmaceutical Ingredient Excipient Market Research Report 2025
Biopharmaceuticals Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical Excipient Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Excipients Emulsifier Market Research Report 2025
Specialty Biopharmaceutical Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Global Pharmaceutical Extruder Market Research Report 2025
Pharma Extruder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemical Dosing Units Market Research Report 2025
Global Anti counterfeiting Pharmaceutical Packaging Market Research Report 2024
Global Pharmaceutical Excipients Malic Acid Market Research Report 2025
Global Rigid Plastic Pharmaceutical Packaging Market Research Report 2024
Global Exosome Diagnostic and Therapeutics Market Research Report 2024
Global Smart Packaging for Pharmaceuticals Market Research Report 2025
Global Pharmaceutical Industry Extruder Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions